Searchable Patents Journal

Search details
          Search details help

   Results per page

Currently viewing: Intellectual Property Office - Patents Journal : SPCs
From 2015 August 26th - 6588 to 2015 August 26th - 6588
Refine: 

  • Help on this tab
    • Page
    • Previous
    • 1
    • Next
Publication
Date
SPC No.SPC
Category
Details
Rows may repeat to show multiple inventors or applicants depending on "Sort By"
26 August 2015
(Journal 6588)
SPC/GB02/019Entered Into ForceApplicant: BASF AKTIENGESELLSCHAFT
Carl-Bosch-Strasse 38, 67063 Ludwigshafen, Germany

Product: pyraclostrobin

Product Type: Plant Protection
Authorised: DE 4951-00 23 October 2001
UK MAPP 10875 21 November 2001

Authorised Extension:

Patent No: EP0804421
Title: Use if 2-(dihydro) pyrazolyl-3'- oxymethylene-anilides as pest-control agents and fungicides

SPC No: SPC/GB02/019
Date entered into force: 21 June 2015
Effective Period Expires On: 22 October 2016
26 August 2015
(Journal 6588)
SPC/GB03/010ExpiredApplicant: GE Healthcare Limited
Amersham Place, Little Chalfont, Buckinghamshire, HP7 9NA

Product: Ioflupane (¹²³I) or [¹²³I]-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-8-(3-fluoropropyl)-nortropane

Product Type: Medicinal
Authorised: UK EU/1/00/135/001 2 August 2000

Authorised Extension:

Patent No: EP0703791
Title: AN IODINATED NEUROPROBE FOR MAPPING MONOAMINE REUPTAKE SITES

SPC No: SPC/GB03/010
Date Expired: 1 August 2015
26 August 2015
(Journal 6588)
SPC/GB15/049LodgedApplicant: BASF AGROCHEMICAL PRODUCTS B.V.
Groningensingel 1, 6835 EA Arnhem, Netherlands

Product: Mixtures comprising imazamox and quinmerac

Product Type: Plant Protection
Authorised: AU 191.047/21-BAES/14 15 May 2014
UK 0272 of 2015 11 February 2015

Authorised Extension:

Patent No: EP1980149
Title: Synergistically acting herbicidal mixtures

SPC No: SPC/GB15/049
Date Lodged: 28 July 2015
26 August 2015
(Journal 6588)
SPC/GB15/050LodgedApplicant: Holostem Terapie Avanzate S.r.L.
Via Glauco Gottardi 100, 41100 Modena, Italy

Product: Ex vivo expanded autologous human corneal epithelial cells containing stem cells.

Product Type: Medicinal
Authorised: UK EU/1/14/987/0001 19 February 2015

Authorised Extension:

Patent No: EP1451302
Title: In vitro reconstituted sheets of human corneal epithelium and method of producing the same.

SPC No: SPC/GB15/050
Date Lodged: 29 July 2015
26 August 2015
(Journal 6588)
SPC/GB15/051LodgedApplicant: Wyeth Holdings LLC
235 East 42nd Street, New York, New York 10017, USA

Product: Neisseria meningitidis group B fHbp fusion protein and a PorA protein

Product Type: Medicinal
Authorised: UK EU/1/12/812 14 January 2013

Authorised Extension:

Patent No: EP2343308
Title: Novel immunogenic compoaitions for the prevention and treatment of meningococcal disease.

SPC No: SPC/GB15/051
Date Lodged: 31 July 2015
26 August 2015
(Journal 6588)
ExpiredGenentech, Inc.
1DNA Way
South San Francisco
CA 94080-4990
United States of America

Product: Etanercept

Product Type: Medicinal
Authorised:
CH 55365 - 1 February 2000
UK EU/1/99/126/001 - 3 February 2000

Authorised Extension:
C (2012) 5615 FINAL - 31July 2012
Patent No: EP1029870
Title: Hybrid immunoglobulins for use in therapeutic methods

SPC Number SPC/GB08/056

Date Extension Granted: 20 May 2013 (See Journal No 6473 12/06/2013)

Extension Expired On: 31 July 2015
26 August 2015
(Journal 6588)
ExpiredPfizer Ireland Pharmaceuticals
Operations Support Group
Ringaskiddy
Co Cork
Ireland

Product:
Recombinant TNF-R p75 IgG fusion protein lacking the first constant region of the heavy chain of human IgG, such as Etanercept

Product Type: Medicinal
Authorised:
CH SWISS 55365 - 1 February 2000
UK EU/1/99/126/001 - 3 February 2000
UK EU/1/99/126/002 - 3 February 2000

Authorised Extension:
EU/1/99/126/001-022 -3 February 2000

Patent No: EP0939121
Title: TNF BINDING PROTEINS

SPC Number: SPC/GB03/027

Date Extension Granted:
11 April 2013 (See Journal No 6468 08/05/2013)

Extension Expired On: 31 July 2015
26 August 2015
(Journal 6588)
ExpiredImmunex Corporation
One Amgen Center Drive
Thousand Oaks
CA 91320-1799
United States of America

Product:
Etanercept

Product Type: Medicinal
Authorised: CH 55365 -1 February 2000
UK EU/1/99/126/001 - 3 February 2000

Authorised Extension: EU/1/99/126/001-022 - 3 February 2000

Patent No: EP0418014
Title: Tumor necrosis factor-alpha and beta receptors

SPC Number SPC/GB00/015
Date Extension Granted :12 March 2013 ( See Journal No 6463 03/04/2013)

Extension Expired On: 31 July 2015
  • Page 1 of 1 (8 hits)
  • Page
  • Previous
  • 1
  • Next

Tell us about a problem